Search

everythinglearnresearchcommunity

for

Search:↓

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

PRP may help with aging and osteoarthritis, improving tissue repair and reducing surgery risk.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Meis1 is crucial for skin health and tumor development.

Melatonin receptor genes likely play an important role in the development of goose feather follicles.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The ZIP7 gene helps control zinc levels in cells by moving zinc from the Golgi apparatus to the cytoplasm.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Runx1 affects hair growth, cancer development, and autoimmune diseases in epithelial tissues.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Some stem cells in the body rarely divide, which could help create better treatments for diseases and aging.

Young women with PCOS without additional risk factors may have normal heart function.

EF and PXE not closely related.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

Zinc is essential for many body functions and imbalances can lead to health problems.